Skip to main content

Clinical Research from Clinical Investigation Services

Call Today to Qualify

Open Hours

Monday – Friday 8 am to 5pm

Psoriatic Arthritis (INSPIRE 1)

Have you been diagnosed with Psoriatic Arthritis?

Trial Information:

The INSPIRE 1 trial by SunPharma will test how effective, safe and tolerable the study drug, tildrakizumab, is compared to placebo in the treatment of psoriatic arthritis. Tildrakizumab is an antibody being tested or used for different conditions such as psoriatic arthritis.These are conditions related to how your immune system is functioning. An antibody is a protein made by the body’s immune (defense) system to fight infection by binding other proteins and molecules.

Rheumatoid Arthritis (Xbiotech Study)

Have you been diagnosed with Rheumatoid Arthritis?

Trial Information:

The Xbiotech 2021-PT055 study will assess the safety and effectiveness of Natrunix (human antibody preparation) in combination with Methotrexate (MTX) to determine the ACR 20 response rate. ACR response is the measure of improvement in percentage of RA disease. The disease activity is checked at two different time points, one before the study drug and one after the study drug.

Acute Coronary Syndrome (LIBREXIA Study)

Have you been diagnosed with Acute Coronary Syndrome (ACS)?

Trial Information:

The LIBREXIA 3003 study by Janssen will study if an experimental drug called milvexian is safe and useful in reducing risk of developing blood clots, stroke, or another heart attach among subjects with a recent heart attack or angina episode, compared to placebo (tablet with no active drug) in addition to standard medication.

Atrial Fibrillation (LIBREXIA Study)

Have you been diagnosed with Atrial Fibrillation (AFib)?

Trial Information:

The LIBREXIA 3002 study by Janssen will compare the effects of an experimental drug, milvexia, to the comparator drug, apixaban, to determine if it is safe and useful in reducing the risk of stroke and blood clots outside the brain (non-central nervous system (CNS) systemic embolism) in participants with atrial fibrillation.

Type 2 Diabetes & Metformin (REIMAGINE 2)

Have you been diagnosed with Type 2 Diabetes? Are you currently taking metformin?

The REIMAGINE 2 trial by Novo Nordisk compares the efficacy of CagriSema in lowering the blood sugar and body weight of people with type 2 diabetes who are treated with metformin, with or without a semaglutide inhibitor. The efficacy of the study drug will be compared to semaglutide, cagrilintide, and a placebo.

Dr. John Agaiby, MD is the leading physician (principal investigator) for this trial at our clinic in Gurnee, IL. We are currently accepting new patients for this study.

Hypertriglyceridemia (CORE2 Study)

Have You Been Diagnosed with Hypertriglyceridemia? 

Clinical Investigation Specialists (CIS) is now enrolling for the CORE2 clinical research study at our Kenosha clinic.

This study is for those with high triglyceride levels or have been diagnosed with hypertriglyceridemia.

Give us a call today at (262) 925-1280 or fill out the questionnaire below to see if this study might be right for you.

Dr. Eva Agaiby

President, Director of Clinical Trials & Regulatory Affairs

View Profile

Allen Banoub, MBA

Director of Marketing & Business Development

View Profile